'''حاد کرونري ساينډروم''' ''(په انګرېزي:Acute coronary syndrome)'' د هرو هغو علايمو ډلې ته وييل کېږي چې د کرونري شريانونو د بندېدلو سره تړاو لري. د حاد کرونري ساينډروم تر ټولو عامه نښه چې د تشخيص لپاره لار پرانېزي ټټرخوږی دی چې اکثراً کيڼ مټ يا ژامې لور خوځېږي، ناروغ اکثراً، درد د فشار سره ورته او يا داسې چې چا يې زړه په موټ کې ټينګ نيولی وي يا هم يو دروند شی يې پر ټټر پروت وي چې له کبله يې ناروغ په سمه سا نشي اخيستلی، په دغو عبارتونو خپل درد څرګندوي، د درد سره ملې نورې نښې زړه بدوالی او خوله کول هم دي. حاد کرونري ساينډروم اکثراً د دغو روغتيايي ستونزو څخه د هرې يوې ستونزې په نتيجه کې پېښېږي: [[ST هسک مايوکارډيل انفارکشن]] (30%) يا په ساده وينا د زړه د دېوالونو سيمه ايزه مړينه چې د زړه ګراف د ST څپې هسکېدنه ښکاره کوي، [[ST ناهسک مايوکارډيل انفارکشن]] (25%) يا په ساده وينا د زړه د دېوالونو سيمه ايزه مړينه چې د زړه ګراف د ST څپې هسکېدنې نه ښکاره کوی، او يا هم [[ناثابته انجاينا]] (38%) يا په ساده وينا ناثابته ټټرخوږی چې د لږ ستومانۍ او د زړه د پمپېدنې د کچې په لوړېدو سره ټټرخوږی رامېنځ ته کېږي.<ref>{{cite journal |author=Torres M, Moayedi S |title=Evaluation of the acutely dyspneic elderly patient |journal=Clin. Geriatr. Med. |volume=23 |issue=2 |pages=307–25, vi |year=2007 |month=May |pmid=17462519 |doi=10.1016/j.cger.2007.01.007 |url=}}</ref>

د ST هسک مايوکارډيل انفارکشن (STEMI) او ST ناهسک مايوکارډيل انفارکشن (NSTEMI) د زړه ګراف د ښکارېدنې له مخې ډلبندي شوي حالتونه دي.<ref name="pmid12791748">{{cite journal |author=Grech ED, Ramsdale DR |title=Acute coronary syndrome: unstable angina and non-ST segment elevation myocardial infarction |journal=BMJ |volume=326 |issue=7401 |pages=1259–61 |year=2003 |month=June |pmid=12791748 |pmc=1126130 |doi=10.1136/bmj.326.7401.1259 |url=http://bmj.com/cgi/pmidlookup?view=long&pmid=12791748}}</ref> داسې يو ډول وضع شوي توپيري معيارونه شته چې دا په ډاګه کړي چې دمايوکارډيل انفارکشن کومه ډله په حاد کرونري ساينډروم کې وشمېرل شي.<ref name="urlDorlands Medical Dictionary:acute coronary syndrome">{{cite web |url=http://www.mercksource.com/pp/us/cns/cns_hl_dorlands_split.jsp?pg=/ppdocs/us/common/dorlands/dorland/nine/14170699.htm |title=Dorlands Medical Dictionary:acute coronary syndrome |work= |accessdate=}}</ref>

د حاد کرونري ساينډروم او د ثابتې انجاينا ترمېنځ بايد ښکاره توپير وشي، ثابته انجاينا د فيزيکي زيار ايستنې په وخت کې او د ستومانېدنې په وخت کې رامېنځ ته کېږي چې د دمې او آرام سره ناروغ بېرته نورمال حالت ته وردرومي. دې حالت ته ناورته ناثابته انجاينا ناڅاپي د دمې او ډېرې لږې زيارايستنې سره پېښېږي او يا هم د فيزيکي زيار ايستنې پرته پېښېږي. د انجاينا د نوې دورې پېښېدنه هم ناثابته انجاينا ګڼل کېږي، دا ځکه چې داسې يو حالت په کرونري شريانونو کې نوې ستونزه ښکاره کوي. 

که څه هم چې حاد کرونري ساينډروم اکثراً د کرونري ترومبوسېز يا د زړه د شريانونو بندېدنې سره اړونده حالت دی، خو دا ډول حالت د کوکاين کارولو سره هم اړونده ګڼل کېږي.<ref>{{cite journal |author=Achar SA, Kundu S, Norcross WA |title=Diagnosis of acute coronary syndrome |journal=Am Fam Physician |volume=72 |issue=1 |pages=119–26 |year=2005  |pmid=16035692 |doi= |url=http://www.aafp.org/afp/20050701/119.html}}</ref> د زړه له کبله ټټرخوږی د وينې د کمښت، براډيکارډيا (له حد نه په ټيټه کچه د زړه د پمپولو عمل) يا ټاکيکارډيا (له حد نه په لوړه کچه د زړه د پمپولو عمل) په وختونو کې هم پېښېدلی شي. 

==نښې نښانې==
زړه ته د کمې اندازې د وينې رسېدلو عمده نښه ټټرخوږی دی چې اکثراً پر زړه باندې د يو ډول فشار په توګه او پورته خوا ژامې، کيڼ ولي او مټ ته د درد د خوځېدو په توګه محسوسېږي. دا ډول حالت د خوله کېدنې، زړه بدوالي او سالنډي سره يو ځای هم راپېښېدلی شي. په ځينو قضيو کې دا ډول ټټرخوږی نه پېښېږي او يا هم په بل ډول محسوسېږي (دا حالت په ښځينه ناروغانو کې او هغو کسانو کې چې د شکرې په ناروغۍ اخته وي او يا هم عمرخوړلي ناروغان وي پېښېږي). ځينې درد د معدې او نس اړونده څرګندوي، په ځينو ناروغانو کې د زړه چټک ټکان، اضطراب او د ناسازۍ احساس هم د دغې ناروغۍ مل علايم ګڼل شوي.

ناروغان اکثراً په ټټر کې د ناراحتۍ څرګندونه د يو ډول فشار ورته بولي او دا ډول څرګندونه په ځانګړي توګه د حاد کرونري ساينډروم په پېژندلو کې ډېره مرسته نه کوي.<ref name=ER09>{{cite journal |author=Woo KM, Schneider JI |title=High-risk chief complaints I: chest pain--the big three |journal=Emerg. Med. Clin. North Am. |volume=27 |issue=4 |pages=685–712, x |year=2009 |month=November |pmid=19932401 |doi=10.1016/j.emc.2009.07.007 |url=}}</ref>

==پېژندنه==
[[انځور:ACS scheme.jpg|کيڼ|بټنوک|300px|د حاد کرونري ساينډروم ډلبندي.<ref name="Alpert-2000">{{cite journal | author=Alpert JS, Thygesen K, Antman E, Bassand JP. | title=Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction | journal=J Am Coll Cardiol | year=2000 | volume=36 | issue=3 | pages=959–69 | pmid=10987628 | doi=10.1016/S0735-1097(00)00804-4}}</ref>]]

===زړه ګراف يا ايلېکټروکارډيوګرام===
د حاد ټټرخوږي په حالت کې د ناروغ د [[زړه ګراف]] يا ايليکټروکارډيوګرام اخيستل د طبي ګروېږنو تر ټولو د اعتماد وړ آزمېښت دی چې د ټټرخوږي د بېلابېلو سببونو پېژندنه پرې کېږي. <ref>{{cite journal |author=Chun AA, McGee SR |title=Bedside diagnosis of coronary artery disease: a systematic review |journal=Am. J. Med. |volume=117 |issue=5 |pages=334–43 |year=2004 |pmid=15336583 |doi=10.1016/j.amjmed.2004.03.021}}</ref> که د زړه ګراف د زړه حاد تخريب ښکاره کړي (د زړه ګراف د ''ST برخې'' هسکېدنه، د کيڼې ګېډۍ څانګې نوی خنډ)، نو په دې وخت کې بايد ډېر ژر د زړه د حملې درملنه، [[انجيوپلاسټي]] يا [[ترومبوليسېز]]  په پام کې ونيول شي (د درملنې برخه لاندې وګورۍ). د زړه په ګراف د داسې يوه حالت د نشتوالي په وخت کې دا امکان نه لري چې په چټکه توګه د [[ناثابته انجاينا]] او د [[ST ناهسک مايوکارډيل انفارکشن]] تر مېنځ توپير وشي.

===د وينې آزمېښتونه او انځورونه===
دا چې د ټټرخوږي يو سبب حاد کرونري ساينډروم دی او داسې نورې ناروغۍ هم شته چې ټټرخوږی يې په عمده علايمو کې راځي نو اکثراً کله چې ناروغ په اېمرجنسي يا بېړنۍ څانګې ته راځي، نو په هغه وخت کې د ټټر اکس رې ، د وينې آزمېښتونه (د زړه د ناروغيو نښګرونه لکه ټروپونين I يا T، او ډي-ډايمر چې که چېرته د سږو اېمبولي وي) او ټيليمېټري (د زړه د پمپولو د رېتم کتنه) ترسره کېږي.

===Prediction scores===
The ACI-TIPI score can be used to aid diagnosis; using 7 variables from the admission record, this score predicts crudely which patients are likely to have myocardial ischemia.<ref name="pmid2072767">{{cite journal |author=Selker HP, Griffith JL, D'Agostino RB |title=A tool for judging coronary care unit admission appropriateness, valid for both real-time and retrospective use. A time-insensitive predictive instrument (TIPI) for acute cardiac ischemia: a multicenter study |journal=Medical care |volume=29 |issue=7 |pages=610–27 |year=1991 |pmid=2072767 |doi=}}</ref> For example according to a [[randomized controlled trial]], males having chest pain with normal or non diagnostic [[ECG]] are at higher risk for having acute coronary syndrome than women.<ref name="pmid19934131">{{cite journal| author=|title=Clinical diagnosis of acute coronary syndrome in patients with chest pain and a normal or non-diagnostic electrocardiogram.|pmid=19934131|year=2009|journal=Emergency medicine journal : EMJ |doi=10.1136/emj.2008.064428| last1=Goodacre| first1=S| last2=Pett| first2=P| last3=Arnold| first3=J| last4=Chawla| first4=A| last5=Hollingsworth| first5=J| last6=Roe| first6=D| last7=Crowder| first7=S| last8=Mann| first8=C| last9=Pitcher| first9=D| volume=26| issue=12| pages=866–70}}</ref> In this study, the [[sensitivity (tests)|sensitivity]] was 65.2% and [[specificity (tests)|specificity]] was 44%. This particular study had an 8.4% prevalence of acute coronary syndrome, which means the [[positive predictive value]] of being a male with chest pain and having coronary syndrome is 9.6% and [[negative predictive value]] is 93.2% ( [http://medinformatics.uthscsa.edu/calculator/calc.shtml?calc_dx_SnSp.shtml?prevalence=8.4&sensitivity=65.2&specificity=44 click here] to adjust these results for patients at higher or lower risk of acute coronary syndrome).

In a second [[cohort study]], exercise electrocardiography was similarly found to be a poor predictor of acute coronary syndrome at follow-up.<ref name="pmid19008264">{{cite journal| author=|title=Incremental prognostic value of the exercise electrocardiogram in the initial assessment of patients with suspected angina: cohort study.|year=2008|journal=BMJ(Clinical research ed.) |pmid=19008264|pmc=2583389|doi=10.1136/bmj.a2240| last1=Sekhri| first1=N| last2=Feder| first2=GS| last3=Junghans| first3=C| last4=Eldridge| first4=S| last5=Umaipalan| first5=A| last6=Madhu| first6=R| last7=Hemingway| first7=H| last8=Timmis| first8=AD| volume=337| pages=a2240}}</ref> Of the patients who had a coronary event at 6 years of follow up, 47% had a negative ECG at the start of the study. With an average follow up of 2.21 years the [[receiver operating characteristic]] curves gave resting ECG a score of 0.72 and exercise ECG a score of 0.74.

==مخنيوی==
حاد کرونري ساينډروم اکثراً د اتېروسکلېروسېز په سبب د زړه کرونري شريانونو ته د تخريب په سبب رامېنځ ته کېږي. د اتروسکلېروسېز د مخنيوي په خاطر بايد د دغې ناروغۍ عاملين کنټرول شي: د ساري په توګه صحي خوراک، ورزش، د وينې د لوړ فشار او د شکرې د ناروغۍ درملنه، د سېګرېټ څښلو نه ډډه او د وينې د کولېسټرول د کچې کنټرولېدنه، په هغو ناروغانو کې چې دا عاملونه موندل کېږي د اسپرين کارول، د اسپرين په اړه زده کړو ښودلې چې دا درمل د زړه او رګونو د ناروغيو د پېښېدلو خطر کموي. 

After a ban on smoking in all enclosed public places was introduced in Scotland in March 2006, there was a 17 percent reduction in hospital admissions for acute coronary syndrome. 67% of the decrease occurred in non-smokers.<ref>{{cite journal| doi=10.1056/NEJMsa0706740| title=Smoke-free Legislation and Hospitalizations for Acute Coronary Syndrome| year=2008| author=Pell JP, Haw S, Cobbe S ''et al.''| journal=New England Journal of Medicine| volume=359| pages=482–91| pmid=18669427| issue=5}}</ref>

==درملنه==
People with presumed ACS are typically treated with [[aspirin]], [[Clopidogrel]], [[nitroglycerin]], and if the chest discomfort persists [[morphine]].<ref name=AHA10>{{cite journal |author=O'Connor RE, Brady W, Brooks SC, ''et al.'' |title=Part 10: acute coronary syndromes: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care |journal=Circulation |volume=122 |issue=18 Suppl 3 |pages=S787–817 |year=2010 |month=November |pmid=20956226 |doi=10.1161/CIRCULATIONAHA.110.971028 |url=}}</ref> Other [[analgesics]] such as [[nitrous oxide]] are of unknown benefit.<ref name=AHA10/>

===ST هسک مايوکارډيل انفارکشن===
{{main|مايوکارډيل انفارکشن}}

If the ECG confirms changes suggestive of [[myocardial infarction]] (ST elevations in specific leads, a new left bundle branch block or a true posterior MI pattern), [[thrombolytics]] may be administered or [[angioplasty|primary coronary angioplasty]] may be performed. In the former, medication is injected that stimulates [[fibrinolysis]], destroying blood clots obstructing the [[coronary artery|coronary arteries]]. In the latter, a flexible catheter is passed via the femoral or radial [[arteries]] and advanced to the heart to identify blockages in the coronaries. When occlusions are found, they can be intervened upon mechanically with [[angioplasty]] and usually [[stent]] deployment if a lesion, termed the ''culprit'' lesion, is thought to be causing myocardial damage.  Data suggest that rapid [[triage]], transfer and treatment is essential.<ref>{{cite journal | author = Blankenship JC, Skelding KA | year = 2008 | title = Rapid Triage, Transfer, and Treatment with Percutaneous Coronary Intervention for Patients with ST-Segment Elevation Myocardial Infarction | url = http://www.remedicajournals.com/Acute-Coronary-Syndromes/showarticleattachment.aspx?aaid=4400&PortalID=71 | journal = Acute Coronary Syndromes | volume = 9 | issue = 2| pages = 59–65 }}</ref> The time frame for door-to-needle thrombolytic administration according to [[American College of Cardiology]] (ACC) guidelines should be within 30 minutes, whereas the door-to-balloon Percutaneous Coronary Intervention (PCI) time should be less than 90 minutes.  It was found that [[thrombolysis]] is more likely to be delivered within the established ACC guidelines among patients with [[STEMI]] as compared to PCI according to a [[case control]] study .<ref name="pmid19898701">{{cite journal| author=|title=Thrombolysis versus primary percutaneous coronary intervention for ST elevation myocardial infarctions at Chilliwack General Hospital.|year=2009|journal=The Canadian journal of cardiology |pmid=19898701|pmc=2776568|doi=| last1=Janda| first1=SP| last2=Tan| first2=N| volume=25| issue=11| pages=e382–4}}</ref>

===ST ناهسک مايوکارډيل انفارکشن او  ST ناهسک-حاد کرونري ساينډروم===
If the ECG does not show typical changes, the term "non-ST segment elevation ACS" is applied. The patient may still have suffered a "non-ST elevation MI" (NSTEMI). The accepted management of unstable angina and acute coronary syndrome is therefore empirical treatment with [[aspirin]], [[heparin]] (usually a [[low-molecular weight heparin]] such as [[enoxaparin]]) and [[clopidogrel]], with intravenous [[Glyceryl trinitrate (pharmacology)|glyceryl trinitrate]] and [[opioid]]s if the pain persists.

A blood test is generally performed for cardiac troponins twelve hours after onset of the pain. If this is positive, [[coronary angiography]] is typically performed on an urgent basis, as this is highly predictive of a heart attack in the near-future. If the troponin is negative, a treadmill exercise test or a thallium scintigram may be requested.

If there is no evidence of ST segment elevation on the [[electrocardiogram]], delaying urgent [[angioplasty]] until the next morning is not inferior to doing so immediately.<ref name="pmid19724041">{{cite journal| author=Montalescot G, Cayla G, Collet JP, Elhadad S, Beygui F, Le Breton H et al.| title=Immediate vs delayed intervention for acute coronary syndromes: a randomized clinical trial. | journal=JAMA | year= 2009 | volume= 302 | issue= 9 | pages= 947–54 | pmid=19724041 | doi=10.1001/jama.2009.1267 }}</ref>

In a [[cohort study]] comparing [[NSTEMI]] and [[STEMI]], patients with [[NSTEMI]] had statistically similar [[wikt:mortality|mortality]] at one year after [[Percutaneous coronary intervention|PCI]] as compared to patients with [[STEMI]] (3.4% vs 4.4%).<ref name="pmid16860018">{{cite journal| author=|title=Comparative early and late outcomes after primary percutaneous coronary intervention in ST-segment elevation and non-ST-segment elevation acute myocardial infarction (from the CADILLAC trial).|year=2006|journal=The American journal of cardiology|pmid=16860018|pmc=|doi=10.1016/j.amjcard.2006.01.102| last1=Cox| first1=DA| last2=Stone| first2=GW| last3=Grines| first3=CL| last4=Stuckey| first4=T| last5=Zimetbaum| first5=PJ| last6=Tcheng| first6=JE| last7=Turco| first7=M| last8=Garcia| first8=E| last9=Guagliumi| first9=G| volume=98| issue=3| pages=331–7}}</ref> However, NSTEMI had significantly more "major cardiac events" (death, [[myocardial infarction]], disabling [[stroke]], or requiring [[revascularization]]) at one year (24.0% vs 16.6%).

[[Cocaine]] associated ACS should be managed in a manner similar to other patients with acute coronary syndrome except [[beta blocker]]s should not be used and [[benzodiazepines]] should be administered early.<ref>{{cite journal |author=McCord J, Jneid H, Hollander JE, ''et al.'' |title=Management of cocaine-associated chest pain and myocardial infarction: a scientific statement from the American Heart Association Acute Cardiac Care Committee of the Council on Clinical Cardiology |journal=Circulation |volume=117 |issue=14 |pages=1897–907 |year=2008 |month=April |pmid=18347214 |doi=10.1161/CIRCULATIONAHA.107.188950 |url=}}</ref>

==وړاندوينه==
===TIMI score===
The [[TIMI]] risk score can identify high risk patients<ref name="pmid10938172">{{cite journal |author=Antman EM, Cohen M, Bernink PJ, ''et al.'' |title=The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making |journal=JAMA |volume=284 |issue=7 |pages=835–42 |year=2000 |pmid=10938172 |doi=10.1001/jama.284.7.835}}</ref> and has been independently validated.<ref name="pmid16365321">{{cite journal |author=Pollack CV, Sites FD, Shofer FS, Sease KL, Hollander JE |title=Application of the TIMI risk score for unstable angina and non-ST elevation acute coronary syndrome to an unselected emergency department chest pain population |journal=Academic Emergency Medicine |volume=13 |issue=1 |pages=13–8 |year=2006 |pmid=16365321 |doi=10.1197/j.aem.2005.06.031}}</ref><ref name="pmid16934646">{{cite journal |author=Chase M, Robey JL, Zogby KE, Sease KL, Shofer FS, Hollander JE |title=Prospective validation of the Thrombolysis in Myocardial Infarction Risk Score in the emergency department chest pain population |journal=Annals of Emergency Medicine |volume=48 |issue=3 |pages=252–9 |year=2006 |pmid=16934646 |doi=10.1016/j.annemergmed.2006.01.032}}</ref>

===د پېژندنې ژونښګرونه ===
The aim of diagnostic markers is to identify patients with ACS even when there is no evidence of heart muscle damage.
*Ischemia-Modified Albumin (IMA) - In cases of Ischemia - Albumin undergoes a conformational change and loses its ability to bind transitional metals (copper or cobalt). IMA can be used to assess the proportion of modified albumin in ischemia. Its use is limited to ruling out ischemia rather than a diagnostic test for the occurrence of ischemia.
*Myeloperoxidase (MPO) - The levels of circulating MPO, a leukocyte enzyme, elevate early after ACS and can be used as an early marker for the condition.

*Glycogen Phosphorylase Isoenzyme BB-([[GPBB]]) is an early marker of cardiac ischemia and is one of three [[isoenzymes|isoenzyme]] of Glycogen Phosphorylase.

*[[Troponin]] is a late cardiac marker of ACS

===Biomarkers for Risk Stratification===
The aim of prognostic markers is to reflect different components of pathophysiology of ACS. For example:
*Natriuretic peptide - Both B-type natriuretic peptide (BNP) and N-terminal Pro BNP can be applied to predict the risk of death and heart failure following ACS.
*Monocyte chemo attractive protein (MCP)-1 - has been shown in a number of studies to identify patients with a higher risk of adverse outcomes after ACS.

==سرچينې==
{{reflist|2}}

{{د زړه ناروغۍ}}


[[وېشنيزه:طبي بېړني حالتونه]]
[[وېشنيزه:د زړه اسکيميکې ناروغۍ]]
